Drupal.behaviors.print = function(context) {window.print();window.close();}>
US Diagnostics Business Drives up Meridian Bioscience Q1 Revenues 13 Percent
January 23, 2013
US Diagnostics Business Drives up Meridian Bioscience Q1 Revenues 13 Percent
By
a GenomeWeb staff reporter
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
Meridian Bioscience Q4 Revenues Rise 6 Percent; MDx Business Continues to Grow
November 8, 2012 / GenomeWeb Daily News
FDA Clears Meridian's Group A Streptococcus MDx Test
September 17, 2012 / GenomeWeb Daily News
Enzo Posts Nearly Flat Q1 Revenue Growth; Developing New MDx Platforms
December 13, 2011 / GenomeWeb Daily News
Cepheid's Q3 Revenues Rise 25 Percent
October 21, 2011 / GenomeWeb Daily News
Meridian's Q4, FY2010 Financial Results Disappoint
November 11, 2010 / GenomeWeb Daily News